Valproic acid oral solution is indicated for: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures 1.1 Epilepsy Valproic acid oral solution is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures.
From the U.S. FDA-approved label for Valproic acid (sodium valproate). Full label: DailyMed.
Valproic acid oral solution is indicated for: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures 1.1 Epilepsy Valproic acid oral solution is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. See Warnings and Precautions for statement regarding fatal hepatic dysfunction. For prophylaxis of migraine headaches, valproate is contraindicated in women who are pregnant and in women of childbearing potential who are not using effective contraception.
From the U.S. FDA-approved label for Valproic acid (sodium valproate). Full label: DailyMed.
Valproic acid oral solution is intended for oral administration. Simple and Complex Absence Seizures: Start at 10 to 15 mg/kg/day, increasing at 1 week intervals by 5 to 10 mg/kg/week until seizure control or limiting side effects Safety of doses above 60 mg/kg/day is not established 2.1 Epilepsy Valproic acid oral solution is intended for oral administration. Patients should be informed to take valproic acid oral solution every day as prescribed.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Valproic acid should not be administered to patients with hepatic disease or significant hepatic dysfunction. Valproic acid is contraindicated in patients known to have mitochondrial disorders caused by mutations in mitochondrial DNA polymerase γ (POLG; e.g., Alpers-Huttenlocher Syndrome) and children under two years of age who are suspected of having a POLG-related disorder. Valproic acid is contraindicated in patients with known hypersensitivity to the drug. Valproic acid is contraindicated in patients with known urea cycle disorders.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Hepatotoxicity; evaluate high risk populations and monitor serum liver tests Birth defects, decreased IQ, and neurodevelopmental disorders following in utero exposure; should not be used to treat women with epilepsy or bipolar disorder who are pregnant or who plan to become pregnant or to treat a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are described below and elsewhere in the labeling: Hepatic failure Birth defects Decreased IQ following in utero exposure Pancreatitis Hyperammonemic encephalopathy Suicidal behavior and ideation Bleeding and other hematopoietic disorders Hypothermia Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan hypersensitivity reactions Because clinical studies are conducted…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
224 products from 97 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Encorate 100mg Injection | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate 133.5mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate 200 mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate 200mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate 333mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate Chrono 200 200mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate Chrono 300 300mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate Chrono 500 500mg Tablet | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Encorate Syrup | Sodium Valproate (valproic acid) | Sun Pharmaceutical Industries Ltd. | |
| Epilex 500mg Tablet | Sodium Valproate (valproic acid) | Abbott India Ltd. | |
| Epilex chrono 200mg Tablet | Sodium Valproate (valproic acid) | Abbott India Ltd. | |
| Epilex Chrono 300mg Tablet | Sodium Valproate (valproic acid) | Abbott India Ltd. | |
| Proate 200 133.5mg + 58mg Tablet | Sodium Valproate (valproic acid) | Nepal Pharmaceuticals Pvt. Ltd. | |
| Proate 300 200mg + 87mg Tablet | Sodium Valproate (valproic acid) | Nepal Pharmaceuticals Pvt. Ltd. | |
| Torvate 200mg Tablet | Sodium Valproate (valproic acid) | Torrent Pharmaceuticals Ltd. | |
| Torvate 300mg Tablet | Sodium Valproate (valproic acid) | Torrent Pharmaceuticals Ltd. | |
| Torvate 500 500mg Tablet | Sodium Valproate (valproic acid) | Torrent Pharmaceuticals Ltd. | |
| Torvate 750 750mg Tablet | Sodium Valproate (valproic acid) | Torrent Pharmaceuticals Ltd. | |
| Valcontin 200mg Tablet | Sodium Valproate (valproic acid) | Modi Mundi Pharma Pvt Ltd. | |
| Valcontin 300mg Tablet | Sodium Valproate (valproic acid) | Modi Mundi Pharma Pvt Ltd. | |
| Valcontin 500mg Tablet | Sodium Valproate (valproic acid) | Modi Mundi Pharma Pvt Ltd. | |
| Valparin 200 200mg Tablet | Sodium Valproate (valproic acid) | Sanofi India Ltd. | |
| Valparin Alkalets 500mg Tablet | Sodium Valproate (valproic acid) | Sanofi India Ltd. | |
| Valparin Chrono 133mg Tablet | Sodium Valproate (valproic acid) | Sanofi India Ltd. | |
| Valparin Chrono 200mg Tablet | Sodium Valproate (valproic acid) | Sanofi India Ltd. | |
| Valparin Chrono 500mg Tablet | Sodium Valproate (valproic acid) | Sanofi India Ltd. | |
| Valpex CR 200mg Tablet | Sodium Valproate (valproic acid) | Alkem Laboratories Ltd. | |
| Valpex CR 300mg Tablet | Sodium Valproate (valproic acid) | Alkem Laboratories Ltd. | |
| Valpex CR 500mg Tablet | Sodium Valproate (valproic acid) | Alkem Laboratories Ltd. | |
| Valporil 200mg Tablet | Sodium Valproate (valproic acid) | Reliance Formulation Pvt Ltd. |
Showing 30 of 224 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.